<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
OCUL
Ocular Therapeutix
$
()


  • What You Missed On Wall Street On Thursday

    4/18/2024 - 16:26pm
  • What You Missed On Wall Street This Morning

    4/18/2024 - 12:00pm
  • Ocular Therapeutix announces results from Phase 1 data for AXPAXLI

    4/18/2024 - 07:08am
  • Ocular Therapeutix announces appointments of CMO, CDO

    4/16/2024 - 07:13am
  • Ocular Therapeutix appoints Dugel as President, CEO

    4/15/2024 - 07:04am
  • Ocular Therapeutix reports inducement grants under Nasdaq listing rule

    4/9/2024 - 07:32am
  • Ocular Therapeutix announces Phase 2 PAXTRAVA glaucoma data

    4/7/2024 - 06:29am
  • Ocular Therapeutix files to sell 43.22M shares of common stock for holders

    3/25/2024 - 16:43pm
  • Ocular Therapeutix price target raised by $3 at H.C. Wainwright, here's why

    3/13/2024 - 06:10am
  • Ocular Therapeutix price target raised by $3 at TD Cowen, here's why

    3/12/2024 - 07:25am
  • Ocular Therapeutix price target raised by $12 at JMP Securities, here's why

    3/12/2024 - 06:18am
  • Fly Intel: After-Hours Movers

    3/11/2024 - 19:01pm
  • Ocular Therapeutix reports Q4 EPS (35c), consensus (30c)

    3/11/2024 - 16:23pm
  • Ocular Therapeutix options imply 11.5% move in share price post-earnings

    3/11/2024 - 14:04pm
  • Ocular Therapeutix options imply 8.8% move in share price post-earnings

    3/4/2024 - 14:04pm
dynamic_feed Breaking News